Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | NT9X3 | — |
dose administered was the 2nd dose of Engerix-B, and that it had expired; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 50-year-old male patient who received HBV (Engerix B) (batch number NT9X3, expiry date 09-SEP-2024) for prophylaxis. On 08-MAY-2025, the patient received the 2nd dose of Engerix B. On 08-MAY-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: dose administered was the 2nd dose of Engerix-B, and that it had expired). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 08-MAY-2025 The nurse reported that she had administered a HepB vaccination, and it is expired which led to, expired vaccine used.